» Articles » PMID: 3583449

Cellular Heterogeneity and Drug Resistance in Two Ovarian Adenocarcinoma Cell Lines Derived from a Single Patient

Overview
Journal Int J Cancer
Specialty Oncology
Date 1987 Jun 15
PMID 3583449
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Two ovarian cell lines were derived from the ascites of a patient before and after the onset of resistance to chemotherapy involving cis-platinum, chlorambucil and 5-fluorouracil. Characterization of these lines shows them to have various features in common and some significant differences. Cytologically the lines cannot be distinguished and they both contain high concentrations of oestrogen receptor. However, they do differ with respect to their growth characteristics, karyotype, glutathione content and sensitivity to cis-platinum. The karyotypes of the 2 lines show several marker chromosomes in common but the resistant line contained a chromosome 8 and a 17 which were absent from the earlier sensitive line. This suggests a clonal origin with subsequent divergence to a heterogeneous population.

Citing Articles

Deciphering the ghost proteome in ovarian cancer cells by deep proteogenomic characterization.

Garcia-Del Rio D, Derhourhi M, Bonnefond A, Leblanc S, Guilloy N, Roucou X Cell Death Dis. 2024; 15(9):712.

PMID: 39349928 PMC: 11442847. DOI: 10.1038/s41419-024-07046-1.


Cervical cancer: a tale from HPV infection to PARP inhibitors.

Mann M, Singh V, Kumar L Genes Dis. 2023; 10(4):1445-1456.

PMID: 37397551 PMC: 10311104. DOI: 10.1016/j.gendis.2022.09.014.


Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy.

cerne K, Kelhar N, Resnik N, Herzog M, Vodnik L, Veranic P Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375854 PMC: 10304395. DOI: 10.3390/ph16060907.


Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics.

Morse D, Michalowski A, Ceribelli M, De Jonghe J, Vias M, Riley D Cell Syst. 2023; 14(6):464-481.e7.

PMID: 37348462 PMC: 10424188. DOI: 10.1016/j.cels.2023.05.003.


Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.

Martino J, Siri S, Calzetta N, Paviolo N, Garro C, Pansa M Elife. 2023; 12.

PMID: 37073955 PMC: 10185344. DOI: 10.7554/eLife.80254.